Literature DB >> 19273341

The dual function of the MHC class II transactivator CIITA against HTLV retroviruses.

Giovanna Tosi1, Luisa Bozzo, Roberto S Accolla.   

Abstract

The AIR-1 gene product CIITA is the master regulator of MHC class II gene expression. This makes CIITA a crucial element for triggering antigen presentation to CD4+ T cells and thus the cascade of events leading to an efficient adaptive immune response. Recently we discovered that CIITA is also endowed with the capacity to directly inhibit both HIV-1 and HTLV retroviruses in infected cells by blocking the function of the viral transactivators Tat and Tax. Thus CIITA exerts a dual role against human retroviruses. The first, classical role is the upregulation of MHC class II expression and thus the capacity to present viral antigens to CD4+ T cells. The other, evolutionary new and fundamental role is to inhibit directly viral replication and spreading. We will discuss the molecular mechanisms by which CIITA counteracts specifically viral transactivators. These distinct properties of CIITA will shed new light on the molecular mechanisms of adaptive coevolution of hosts and pathogens and may be exploited to envisage novel therapeutic strategies aimed at counteracting retroviral infections and thus their oncogenic potential..

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273341     DOI: 10.2741/3519

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  7 in total

1.  Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 Tax-1 function and inhibits viral replication.

Authors:  Giovanna Tosi; Greta Forlani; Vibeke Andresen; Marco Turci; Umberto Bertazzoni; Genoveffa Franchini; Guido Poli; Roberto S Accolla
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

2.  Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B.

Authors:  Simon P Fletcher; Daniel J Chin; Donavan T Cheng; Palanikumar Ravindran; Hans Bitter; Lore Gruenbaum; Paul J Cote; Han Ma; Klaus Klumpp; Stephan Menne
Journal:  Hepatology       Date:  2013-01       Impact factor: 17.425

3.  Data driven linear algebraic methods for analysis of molecular pathways: application to disease progression in shock/trauma.

Authors:  Mary F McGuire; M Sriram Iyengar; David W Mercer
Journal:  J Biomed Inform       Date:  2011-12-17       Impact factor: 6.317

Review 4.  Structural aspects of the MHC expression control system.

Authors:  Grady Nash; Bhaskar Paidimuddala; Liman Zhang
Journal:  Biophys Chem       Date:  2022-02-15       Impact factor: 2.352

5.  The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein.

Authors:  Greta Forlani; Rawan Abdallah; Roberto S Accolla; Giovanna Tosi
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

6.  Transcriptional coactivator CIITA, a functional homolog of TAF1, has kinase activity.

Authors:  Katherine C Soe; Ballachanda N Devaiah; Dinah S Singer
Journal:  Biochim Biophys Acta       Date:  2013-09-13

7.  Reversible Human Immunodeficiency Virus Type-1 Latency in Primary Human Monocyte-Derived Macrophages Induced by Sustained M1 Polarization.

Authors:  Francesca Graziano; Giulia Aimola; Greta Forlani; Filippo Turrini; Roberto S Accolla; Elisa Vicenzi; Guido Poli
Journal:  Sci Rep       Date:  2018-09-24       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.